Publications and Presentations

Hasson N. 1989 Cyclosporin in Juvenile Dermatomyositis. Presentation BPNA meeting, Leeds.

Hasson N., Heckmatt J., Saunders C. 1989 Effectiveness of Cyclosporin in Juvenile Dermatomyositis. Presentation Symposium on Research in Neuromuscular Disorders London

Kunaver M., Haskard D.O., Hasson N., 1989 Immunohistochemical Analysis of Skin Biopsies from Children with Juvenile Dermatomyositis. Poster presentation, Symposium on Research in Neuromuscular Disorders, London

Heckmatt J., Hasson N., Saunders C., Thompson N., Peters A.M.,Cambridge G., Rose M., Hyde S.A., Dubowitz V. 1989 Cyclosporin in Juvenile Dermatomyositis. Lancet. 13; 1(8646): 1063-6

Hasson N. 1991 Dermatomyositis – Diagnosis and Treatment. Presentation – Update in Muscle Disease. London

Poulton J., Hasson N., Morten K. 1991 A point mutation in the MELAS Syndrome. Presentation 16th Oxford Symposium on Muscle Disease

Peters A.M., Heckmatt J.Z., Hasson N., Henderson B.L., el-Meleigy D., Rose M.L., Dubowitz V. 1991 Renal haemodynamics of cyclosporine. A nephrotoxicity in children with juvenile dermatomyositis. Clin-Sci-Colch.; 81(2): 153-9

Hasson N., Heckmatt J., Dubowitz V. 1991 The diagnosis and Management of Manifesting Carriers of Xp21 Muscular Dystrophy. Poster Presentation SSIEM Annual Symposium, London

Hasson N. 1991 Home Nasal Ventilation in Muscle Diseases. Presentation New Technologies in Paediatrics, Reggio Emilia, Italy

Morten K., Poulton J., Mathews P., Bindoff L., Hasson N., Brown G. 1992 Detection of Mitochondrial DNA Mutations Associated with the MELAS Syndrome. Poster Presentation, Clinical Genetics Society, Birmingham

Khan Y., Hasson N., Manzur A., 1992 Effect of Nasal Ventilation on Nocturnal Hypoxia in Neuromuscular Patients. Am Rev Respir Dis. 1992;145:A863

Hasson N., David J., Woo P. 1992 Is scleroderma the same disease in childhood- Poster presentation, American College of Rheumatology, Atlanta, October 1992 and abstract Arthritis and Rheumatism, Oct 1992.

Sewry C.A., Sansome A., Clerk A., Sherratt T.G., Hasson N., Rodillo E., Heckmatt J.Z., Strong P.N., Dubowitz V. 1993 Manifesting carriers of Xp21 muscular dystrophy; lack of correlation between dystrophin expression and clinical weakness. Neuromuscular Disorders; 3(2): 141-8

Hasson N., David J., Woo P. 1993 Scleroderma in childhood. Poster presentation, British Society for Rheumatology, Harrogate

Hasson N., David J., Woo P. 1993 Is scleroderma the same disease in childhood- Presentation and abstract, BPA, University of Warwick,

Mier R.., Hasson N., Woo P. 1993 Long term follow-up of children with mixed connective tissue disease. Poster presentation, American College of Rheumatology, San Antonio, and abstract Arthritis and Rheumatism Nov 1993

Hasson N., Ansell B., Rooney M., Woo P., 1993 Chloroquine in seropositve Polyarticular Juvenile Chronic Arthritis. Poster presentation, American College of Rheumatology, San Antonio, and abstract Arthritis and Rheumatism Nov 1993

Hasson N., Rooney M., Ansell B., Woo P. 1994 Chloroquine in Rheumatoid Factor Positive Polyarticular J.C.A. Presentation at BPA, University of Warwick

Rooney M., Varsani H., Hasson N., Woo P .1994 The IL-1ra response to gammaglobulin therapy in systemic juvenile chronic arthritis may predict treatment efficacy. Poster presentation, Second European Conference of paediatric autoimmune and rheumatic diseases, Pavia, Italy

Hasson N., Russell K., Artlett C 1994 Molecular analysis of HLA Class II genes in Juvenile Scleroderma. Poster presentation, Second European Conference of paediatric autoimmune and rheumatic diseases, Pavia, Italy

Hasson N., Hussein M., David J. 1994 Diltiazem Hydrochloride in the treatment of calcinosis of connective tissue disease. Poster presentation, Second European Conference of paediatric autoimmune and rheumatic diseases, Pavia, Italy

Mier R., Ansell B., Hall M.A., Hasson N., Levinson J., Lovell D., Passo M., Rennebohm R., Woo P. 1996 Long term follow-up of children with mixed connective tissue disease. Lupus 5(3): 221-6

Vancheeswaran R., Black C.M., David J., Hasson N., Harper J., Atherton D., Trivedi P., Woo P. 1996 Childhood-onset scleroderma: is it different from adult-onset disease. Arthritis-Rheum. 39(6): 1041-9

Hasson N. 1997 Limb pain in children. Family Medicine

Michie C.A., Hasson N., and Tulloh R. 1998 The neonatal thymus and antenatal steroids [letter] Arch-Dis-Child-Fetal-Neonatal-Ed. 79(2): F159

Woo P., Southwood T. R., Prieur A-M., Dore C.J., Grainger J., David J., Ryder C., Hasson N. Hall A. and Lemelle I. 2000 Randomized, Placebo-controlled, Crossover Trial of Low-dose Oral Methotrexate in Children with Extended Oligoarticular or Systemic Arthritis. Arthritis and Rheumatism 43 (8) 1849-1857

Hasson N. 2002 Rheumatology. In Beattie M. and Champion M. (Eds.) 2002 Essential revision notes in Paediatrics for the MRCPCH Pastest

Urquhart D, Hasson N. 2002 Chondromalacia Patella – Underuse or Overuse Injury- Presentation 6th RCPCH Meeting, York

Maillard S., Pilkington C. and Hasson N. 2004 Physiotherapy management of Benign Joint Hypermobility Syndrome . Poster presentation ACR. Poster Presentation PRES 2005; and abstract Clinical and experimental Rheumatology 22;4 2004 P541

Hasson N. 2005 Chronic Joint Pains – Personal Practice Session. RCPCH Meeting York

Maillard S., Pilkington C. and Hasson N. 2005 The Physiotherapy management of Coxa-vara, Camptodactyly, Arthropathy and Pericarditis (CCAP) Presentation PRES, Versailles and abstract Clinical and Experimental Rheumatology 23;3 Suppl. 37 288

Hasson N. 2005 Hypermobility in Childhood. Presentation BSR Birmingham.

McCann L., Hasson N., Woo P. 2005 Favourable Preliminary Results for the Use of Anti-TNF Therapy in the Treatment of Periodic Fever Syndromes – TRAPS & HIDS: UK Experience in 7 Children. Poster presentation PRES Versailles

Offiah A.C., Woo P., Prieur A-M., Hasson N., Hall C.M. 2005 Camptodactyly-Arthropathy-Coxa Vara-Pericarditis Syndrome Versus Juvenile Idiopathic Arthropathy. American Journal Roentgenology:185:522-529

Marks S.D., Patey S., Brogan P.A., Hasson N., Pilkington C., Woo P., Tullus K.B. 2005 Lymphocyte depletion in children with refractory systemic lupus erythematosus. Arthritis Rheum 52(10):3168-3174

Khawaja, K.W., Trachana, M., Hasson, N., & Pilkington, C 2005 Pamidronates role in the treatment of childhood Chronic Recurrent Multifocal Osteomyelitis. Bone, vol. 36, p. S87

Melo M., Pilkington C., Hasson N., Ozen S., Dolezalova P., Klein N., Tullus K., Marks S., Harper J., Shah V., Woo P., Brogan P.A. 2006 Biologic therapy in primary systemic vasculitis of the young. Presentation – Young Investigators Meeting, PRES

McCann L., Wedderburn L., Hasson N. 2006 Juvenile Idiopathic Arthritis. Archives of Disease in Childhood. Ed. Pract., 91(2): ep29 – ep36.

McCann LJ, Hasson N, Pilkington CA. 2006 Macrophage activation syndrome as an early presentation of Lupus. J Rheumatol. 2006 Feb;33(2):438-40.

Hasson N. 2007 Hypermobility clinics – Who needs them- BSR, Birmingham

Hasson N. 2008 Bone Pain, Invited Lecture RCPCH Annual Meeting, York

Hasson N. 2008 Medical Student Reminiscences – Groote Schuur Hospital for Prof Beighton BSR, Liverpool

Mato H., Hasson N., Pilkington C., and Maillard S. 2008 Spondylo-Epiphyseal Dysplasia – a physiotherapy approach. Presentation accepted for PRES, London

Mato H., Berde T., Hasson N., Grahame R., and Maillard S. 2008 A review of symptoms associated with Benign Joint Hypermobility Syndrome in Children. Poster accepted for PRES London

Maillard S., Howard R., and Hasson N. 2008 Complex Regional Pain Syndrome with dystonia in childhood . Poster accepted for PRES London

Mato H., Sian S., Hasson N., Maillard S. 2008 A review of the management of Complex Regional Pain Syndrome; an experience of an inpatient rehabilitation unit. Poster accepted for PRES London

Marks S., Shah V., Hasson N., Pilkington C., Tullus K. 2008 Urinary and not plasma monocyte chemoattractant protein-1 correlates with disease activity in paediatric systemic lupus erythematosus. Presentation accepted for ESPN Lyon